Stock Research for ARCAY

ARCAY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ARCAY Stock Chart & Research Data

The ARCAY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARCAY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ARCAY Due diligence Resources & Stock Charts

The ARCAY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARCAY Detailed Price Forecast - CNN Money CNN View ARCAY Detailed Summary - Google Finance
Yahoo View ARCAY Detailed Summary - Yahoo! Finance Zacks View ARCAY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ARCAY Trends & Analysis - Trade-Ideas Barrons View ARCAY Major Holders - Barrons
NASDAQ View ARCAY Call Transcripts - NASDAQ Seeking View ARCAY Breaking News & Analysis - Seeking Alpha
Spotlight View ARCAY Annual Report - CompanySpotlight.com OTC Report View ARCAY OTC Short Report - OTCShortReport.com
TradeKing View ARCAY Fundamentals - TradeKing Charts View ARCAY SEC Filings - Bar Chart
WSJ View Historical Prices for ARCAY - The WSJ Morningstar View Performance/Total Return for ARCAY - Morningstar
MarketWatch View the Analyst Estimates for ARCAY - MarketWatch CNBC View the Earnings History for ARCAY - CNBC
StockMarketWatch View the ARCAY Earnings - StockMarketWatch MacroAxis View ARCAY Buy or Sell Recommendations - MacroAxis
Bullish View the ARCAY Bullish Patterns - American Bulls Short Pains View ARCAY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ARCAY Stock Mentions - StockTwits PennyStocks View ARCAY Stock Mentions - PennyStockTweets
Twitter View ARCAY Stock Mentions - Twitter Invest Hub View ARCAY Investment Forum News - Investor Hub
Yahoo View ARCAY Stock Mentions - Yahoo! Message Board Seeking Alpha View ARCAY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ARCAY - SECform4.com Insider Cow View Insider Transactions for ARCAY - Insider Cow
CNBC View ARCAY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARCAY - OTC Markets
Yahoo View Insider Transactions for ARCAY - Yahoo! Finance NASDAQ View Institutional Holdings for ARCAY - NASDAQ


Stock Charts

FinViz View ARCAY Stock Insight & Charts - FinViz.com StockCharts View ARCAY Investment Charts - StockCharts.com
BarChart View ARCAY Stock Overview & Charts - BarChart Trading View View ARCAY User Generated Charts - Trading View




Latest Financial News for ARCAY


Is Arcadis NV's (AMS:ARCAD) Recent Stock Performance Tethered To Its Strong Fundamentals?
Posted on Sunday March 24, 2024

Arcadis (AMS:ARCAD) has had a great run on the share market with its stock up by a significant 20% over the last three...


Here's Why We Think Arcadis (AMS:ARCAD) Is Well Worth Watching
Posted on Sunday March 10, 2024

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...


Arcadis Full Year 2023 Earnings: Revenues In Line With Expectations
Posted on Friday February 23, 2024

Arcadis ( AMS:ARCAD ) Full Year 2023 Results Key Financial Results Revenue: €5.00b (up 24% from FY 2022). Net income...


Arcadis Q4 and Full Year 2023 Results: Record quarter performance and delivery on 2021-2023 targets
Posted on Wednesday February 21, 2024

PRESS RELEASE Arcadis Fourth Quarter and Full Year Results 2023Record quarter performance and delivery on 2021-2023 targets FOURTH QUARTER Record Operating EBITA margin1) of 11.4% (Q4‘22: 10.0%)Record Q4 Order Intake of €1,028 million resulting in Book to Bill of 1.09xRecord Free Cash Flow generation of €208 million (Q4‘22: €146 million) FULL YEAR Delivered on all key strategic targets set for 2021-2023 strategy cycle “Maximizing Impact”Operating EBITA margin of 10.4% (FY ‘22: 9.8%)Record net re


Stock Market & Investing Books

Enter a stock symbol to view the stock details.